The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.11
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.03 (27.273%)
Open: 0.125
High: 0.125
Low: 0.125
Prev. Close: 0.125
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jul 2017 11:10

RNS Number : 4378M
Deltex Medical Group PLC
28 July 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DELTEX MEDICAL GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: MISSED DISCLOSURE DUE TO SHARES IN ISSUE CHANGE

3. Details of person subject to the notification obligationiv

Name

J O HAMBRO CAPITAL MANAGEMENT LIMITED

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27 JULY 2017

6. Date on which issuer notified (DD/MM/YYYY):

28 JULY 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.72%

0.00%

9.72%

313,115,807

Position of previous notification (if

applicable)

10.68%

0.00%

10.68%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0059337583

30,419,696

9.72%

SUBTOTAL 8. A

30,419,696

9.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

-

The number and % of voting rights held

-

The date until which the voting rights will be held

-

11. Additional informationxvi

.

 

 

Place of completion

J O HAMBRO CAPITAL MANAGEMENT, LONDON

Date of completion

28 JULY 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXPAELXEFF
Date   Source Headline
23rd Oct 20137:00 amRNSFDA approves CardioQ-ODM+
23rd Sep 20137:00 amRNSPrivate Investor Event
10th Sep 20137:00 amRNSInterim Results
8th Aug 20137:00 amRNSNotice of Results
1st Aug 20137:00 amRNSUS Authorities Publish ODM Payment Instructions
26th Jul 20133:02 pmRNSAdditional Listing
9th Jul 20139:00 amRNSPre-Close Update
4th Jul 20137:00 amRNSPositive Study from St Thomas's Hospital
25th Jun 201311:30 amRNSIssue of Equity
25th Jun 201311:10 amRNSDirector/PDMR Shareholding
24th Jun 20137:00 amRNSFDA submission completed for CardioQ-ODM+
19th Jun 20137:00 amRNSPremier Update: Successful Pilot Study
18th Jun 20134:11 pmRNSManchester One2One Investors Forum - June 26
30th May 20137:00 amRNSClinical Guidelines for Anaesthetists in France
17th May 201310:25 amRNSDirector/PDMR Shareholding
1st May 20138:47 amRNSResult of AGM
30th Apr 20137:00 amRNSAGM Statement
24th Apr 20135:44 pmRNSHolding(s) in Company
23rd Apr 20138:51 amRNSHolding(s) in Company
12th Apr 20133:23 pmRNSDirector Shareholding and Additional Listing
12th Apr 201312:42 pmRNSDirector/PDMR Shareholding - Replacement
12th Apr 20137:00 amRNSDirector/PDMR Shareholding
10th Apr 20137:00 amRNSUS Govt body grants unique payment code for ODM
25th Mar 20137:00 amRNSFinal Results
18th Mar 20137:00 amRNSOutstanding Achievement Award
4th Feb 20131:42 pmRNSHolding(s) in Company
28th Jan 201310:06 amRNSHolding(s) in Company
23rd Jan 201312:39 pmRNSDirector/PDMR Shareholding
18th Jan 201311:20 amRNSPlacing to raise £2.5 million
8th Jan 20137:00 amRNSPre-close update
24th Dec 20127:00 amRNSNHS sets requirements for Fluid Management
10th Dec 20127:00 amRNSNew study supports the importance of ODM
29th Nov 20127:00 amRNSStudy reinforces CardioQ-ODM competitive advantage
31st Oct 20129:52 amRNSDirector/PDMR Shareholding
25th Oct 20124:47 pmRNSAdditional Listing
23rd Oct 20127:00 amRNSNHS South Innovation Plan
19th Oct 20127:00 amRNSEnhanced Recovery Update
10th Oct 20124:25 pmRNSGrant of options
10th Oct 20124:23 pmRNSIssue of Equity and TVR
19th Sep 20127:00 amRNSInterim Results
9th Aug 20128:23 amRNSHolding(s) in Company
6th Jul 20127:00 amRNSPre-close update on six months ended 30 June 2012
3rd Jul 20127:00 amRNSERP backs wide adoption of CardioQ-ODM
29th Jun 201210:13 amRNSDirector/PDMR Shareholding
22nd May 20124:54 pmRNSIssue of Equity
2nd May 20121:00 pmRNSResult of AGM
16th Apr 20129:35 amRNSHolding(s) in Company (Replacement to 10/04/12)
16th Apr 20129:23 amRNSHolding(s) in Company
10th Apr 20124:58 pmRNSHolding(s) in Company
5th Apr 201211:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.